ACETYLCYSTEINE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 163.0 | -0.5 | 3 | 3 | 66.0 | 3 | 0.6 |
- CAS
- 616911
- UNII
- WYQ7N0BPYC
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 97 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT01021163 | Effects of N-acetylcysteine on Pulmonary Function in High-risk Patients Undergoing Off-pump Coronary Bypass Surgery | Phase 4 | Completed | |
| NCT02040818 | 2017-01-01 | Treatment of Hemodialysis Catheter-Related Bacteremia | Phase 2/Phase 3 | Not Yet Recruiting |
| NCT02094625 | 2015-07-01 | NAC to Prevent Cisplatin-induced Hearing Loss | Phase 1 | Not Yet Recruiting |
| NCT02357303 | 2015-03-01 | Simethicone and N-acetylcysteine in Upper Endoscopy - Prospective Double-blinded Randomized Controlled Trial | Phase 4 | Not Yet Recruiting |
| NCT02362425 | 2015-01-01 | Antioxidant Therapy in RYR1-Related Congenital Myopathy | Phase 1/Phase 2 | Recruiting |
| NCT02379637 | 2015-01-01 | Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough | Phase 2 | Recruiting |
| NCT02348775 | 2014-11-01 | Glutathione and Function in HIV Patients | Phase 1 | Recruiting |
| NCT02348762 | 2014-11-01 | Energetics and Function in Older Humans | Phase 1 | Recruiting |
| NCT02294591 | 2014-10-01 | NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression | Phase 2 | Recruiting |
| NCT02269540 | 2014-10-01 | A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A) | Phase 0 | Recruiting |
| NCT02241876 | 2014-10-01 | THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS | Phase 4 | Not Yet Recruiting |
| NCT02265224 | 2014-09-01 | Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC) | Phase 1 | Completed |
| NCT02212678 | 2014-09-01 | Repeated-Dose Oral N-acetylcysteine for the Treatment of Parkinson's Disease | Phase 2 | Not Yet Recruiting |
| NCT02249546 | 2014-09-01 | Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori Infection | Phase 4 | Recruiting |
| NCT02171104 | 2014-07-01 | MT2013-31:Allo BMT for Metabolic Disorders, Osteopetrosis and Males With Rett Syndrome | Phase 2 | Recruiting |
| NCT02141620 | 2014-05-01 | n-Acetylcysteine and Cocaine | Phase 0 | Recruiting |
| NCT02182167 | 2014-05-01 | A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis | Phase 2/Phase 3 | Recruiting |
| NCT02088216 | 2014-03-01 | Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis | Phase 3 | Active, Not Recruiting |
| NCT02335060 | 2014-03-01 | N-acetylcysteine Effects on Tetrahydrocannabinol | Phase 1 | Recruiting |
| NCT02080182 | 2014-01-01 | Effect of Acetylcysteine in Pediatric Acute Pyelonephritis. | Phase 2 | Recruiting |
| NCT01675661 | 2014-01-01 | Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment | Phase 3 | Recruiting |
| NCT02357290 | 2014-01-01 | Open-Label Study of N-Acetylcysteine in Children and Adolescents 5-17 With Bipolar Spectrum Disorders | Phase 4 | Recruiting |
| NCT01962961 | 2013-10-01 | N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults | Phase 1/Phase 2 | Recruiting |
| NCT01993849 | 2013-10-01 | Use of NAC in Fingernail Biting | Phase 3 | Recruiting |
| NCT02088502 | 2013-09-01 | Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy | Phase 2/Phase 3 | Recruiting |
| NCT02206178 | 2013-09-01 | Acetaminophen's Antinociceptive Effect When Associated With N-Acetylcysteneine | Phase 1 | Recruiting |
| NCT01885338 | 2013-06-01 | N-acetylcysteine (NAC) for Improving Cognitive Dysfunction in Schizophrenia | Phase 1 | Active, Not Recruiting |
| NCT01187108 | 2013-06-01 | Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru | Phase 1/Phase 2 | Completed |
| NCT01808521 | 2013-05-01 | A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura | Phase 0 | Enrolling By Invitation |
| NCT01849016 | 2013-04-01 | N-Acetylcysteine in Patients With Sickle Cell Disease | Phase 3 | Recruiting |
| NCT01800526 | 2013-03-01 | A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease | Phase 0 | Enrolling By Invitation |
| NCT01905696 | 2013-03-01 | The Role of S-nitrosohemoglobin in Regulating Systemic Blood Flow During Hypoxia and Normoxia | Phase 0 | Active, Not Recruiting |
| NCT02124525 | 2013-02-01 | N-acetylcysteine for Tobacco Smoking | Phase 3 | Recruiting |
| NCT01467466 | 2013-02-01 | Prevention of Serious Adverse Events Following Angiography | Phase 3 | Recruiting |
| NCT01664260 | 2012-11-01 | Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress Disorder | Phase 2 | Recruiting |
| NCT01726465 | 2012-11-01 | Methylprednisolone N Acetylcysteine in Hepatic Resections | Phase 2 | Terminated |
| NCT01612221 | 2012-09-01 | Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo | Phase 2 | Recruiting |
| NCT01753752 | 2012-09-01 | Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple Instillation | Phase 2 | Completed |
| NCT01172275 | 2012-07-01 | N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder | Phase 2 | Recruiting |
| NCT01653171 | 2012-07-01 | Premedication With Simethicone or Simethicone Plus N-acetylcysteine in Improving Visibility During Upper Endoscopy | Phase 4 | Completed |
| NCT01878695 | 2012-07-01 | Pilot Study of Anti-oxidant Supplementation With N-Acetyl Cysteine in Stage 0/I Breast Cancer | Phase 1 | Recruiting |
| NCT01555970 | 2012-03-01 | Efficacy Study of add-on Therapy With N-Acetylcysteine in Resistant Obsessive-compulsive Disorder | Phase 2 | Completed |
| NCT01439828 | 2012-02-01 | Clinical Trial of N-acetylcysteine Versus Placebo Efficacy in the Cannabis Withdrawal | Phase 2 | Not Yet Recruiting |
| NCT01537926 | 2012-01-01 | Hypertrophic Regression With N-Acetylcysteine in HCM | Phase 1 | Recruiting |
| NCT01470027 | 2012-01-01 | N-Acetylcysteine for Neuroprotection in Parkinson's Disease | Phase 1/Phase 2 | Recruiting |
| NCT01424033 | 2011-12-01 | Evaluating N-Acetylcysteine in CTD-ILD Treatment | Phase 2/Phase 3 | Recruiting |
| NCT01501110 | 2011-11-01 | Effects of N-acetylcysteine on Low T3 Syndrome | Phase 4 | Recruiting |
| NCT01866644 | 2011-09-01 | Effectiveness of N-acetylcysteine on Preservation Solution During Liver Transplantation | Phase 3 | Recruiting |
| NCT01495260 | 2011-09-01 | A Clinical Trial for AMN: Validation of Biomarkers of Oxidative Stress, Efficacy and Safety of a Mixture of Antioxidants | Phase 2 | Completed |
| NCT01427517 | 2011-07-01 | Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease | Phase 1 | Completed |
| NCT01747616 | 2011-07-01 | Assessment of Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Subjects While Wearing Contact Lenses and Before Insertion of Contact Lenses | Phase 1 | Completed |
| NCT01384591 | 2011-07-01 | Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly | Phase 1/Phase 2 | Active, Not Recruiting |
| NCT01232257 | 2011-07-01 | Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD) | Phase 3 | Completed |
| NCT01572597 | 2011-06-01 | Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy | Phase 4 | Recruiting |
| NCT01354132 | 2011-05-01 | N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis | Phase 4 | Recruiting |
| NCT01278784 | 2011-03-01 | Local Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers | Phase 1 | Completed |
| NCT01111734 | 2011-03-01 | Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents | Phase 1 | Recruiting |
| NCT01704482 | 2011-02-01 | N-acetylcysteine for Renal Protection in Patients With Rheumatic Heart Disease Undergoing Valve Replacement | Phase 2 | Completed |
| NCT01265563 | 2011-01-01 | Glutathione in Diabetic Nephropathy | Phase 2 | Recruiting |
| NCT01251029 | 2011-01-01 | Effect of N-acetylcysteine on Renal Functioning of Chronic Kidney Diseases(CKD) Patients After General Anesthesia | Phase 1 | Not Yet Recruiting |
| NCT01741207 | 2011-01-01 | Effect of N-acetylcystein in Myocardial Infarction | Phase 3 | Recruiting |
| NCT02168387 | 2010-12-01 | Efficacy of Percussive Ventilation Therapy (MetaNeb ®) Compared With Mucolytic Agents for Atelectasis in the Mechanically Ventilated Pediatric Patient | Phase 4 | Completed |
| NCT01214083 | 2010-10-01 | N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence | Phase 2 | Recruiting |
| NCT01381354 | 2010-10-01 | Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) | Phase 1 | Active, Not Recruiting |
| NCT01015209 | 2010-09-01 | Safety and Tolerability of Chitosan-N-acetylcysteine Eye Drops in Healthy Young Volunteers | Phase 1 | Completed |
| NCT01050270 | 2010-09-01 | Scottish and Newcastle Anti-emetic Pre-treatment for Paracetamol Poisoning Study (SNAP) | Phase 4 | Completed |
| NCT01118663 | 2010-09-01 | Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection | Phase 3 | Terminated |
| NCT01394419 | 2010-09-01 | Effect of N-acetylcysteine on Prevention of Acute Kidney Injury in High Risk Patients Undergoing Off-pump Coronary Artery Bypass Graft | Phase 4 | Completed |
| NCT01355198 | 2010-08-01 | Role of HIV on Glutathione Synthesis and Oxidative Stress | Phase 1 | Completed |
| NCT01172288 | 2010-07-01 | N-acetylcysteine (NAC) for Children With Tourette Syndrome | Phase 2 | Completed |
| NCT01271088 | 2010-06-01 | Protective Effect of N-acetylcysteine Against From Ototoxicity | Phase 2/Phase 3 | Completed |
| NCT01138137 | 2010-06-01 | N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer | Phase 1 | Suspended |
| NCT01063205 | 2010-03-01 | NAC as a Potential Treatment for Methamphetamine Dependence | Phase 1 | Completed |
| NCT01111422 | 2010-03-01 | Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients | Phase 4 | Recruiting |
| NCT01131572 | 2010-02-01 | N-acetylcysteine in Bulimia Nervosa | Phase 2/Phase 3 | Terminated |
| NCT00996424 | 2010-01-01 | The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung Function | Phase 4 | Terminated |
| NCT01033149 | 2009-12-01 | N-acetylcysteine in the Treatment of Bulimia Nervosa | Phase 3 | Terminated |
| NCT00650091 | 2009-10-01 | Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF | Phase 3 | Completed |
| NCT00915200 | 2009-10-01 | N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy | Phase 2 | Recruiting |
| NCT01210456 | 2009-10-01 | Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury | Phase 3 | Enrolling By Invitation |
| NCT00993265 | 2009-10-01 | N-Acetylcysteine for Pediatric Trichotillomania | Phase 2 | Completed |
| NCT01005810 | 2009-09-01 | A Trial of N-Acetylcysteine (an Over-the-Counter Medicine) in Adolescents Who Smoke Marijuana | Phase 2 | Recruiting |
| NCT01082445 | 2009-08-01 | Effects of N-acetylcysteine on Diabetic Foot Oxygenation | Phase 3 | Completed |
| NCT00775476 | 2009-03-01 | Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine | Phase 1/Phase 2 | Suspended |
| NCT00969904 | 2009-03-01 | Pilot Study to Assess the Effect of High Dose N-acetylcysteine (NAC) in Chronic Obstructive Pulmonary Disease (COPD) Patients | Phase 4 | Completed |
| NCT00870883 | 2009-03-01 | N-acetylcysteine Plus Deferoxamine for Patients With Hypotension | Phase 2 | Recruiting |
| NCT01017796 | 2009-01-01 | Contrast Agent-associated Nephrotoxicity in Intensive Care Unit Patients | Phase 0 | Active, Not Recruiting |
| NCT00896025 | 2008-12-01 | Study of N-Acetylcysteine in Acute Liver Failure (ALF) | Phase 4 | Terminated |
| NCT00809094 | 2008-11-01 | NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Acetylcysteine On Redox Changes and Lung Inflammation In Cystic Fibrosis Patients | Phase 2 | Completed |
| NCT00724594 | 2008-08-01 | Safety of N-acetylcysteine in Maternal Chorioamnionitis (NAC in Chorio) | Phase 1/Phase 2 | Recruiting |
| NCT00736866 | 2008-08-01 | The Acetylcysteine for Contrast-Induced Nephropathy Trial | Phase 3 | Completed |
| NCT00716001 | 2008-07-01 | Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure | Phase 4 | Not Yet Recruiting |
| NCT01131468 | 2008-02-01 | Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine | Phase 2 | Completed |
| NCT00558142 | 2008-02-01 | Mechanisms for the Effect of Acetylcysteine on Renal Function After Exposure to Radiographic Contrast Material | Phase 4 | Recruiting |
| NCT00542750 | 2008-01-01 | An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents | Phase 1/Phase 2 | Completed |
| NCT00568087 | 2007-12-01 | N-acetylcysteine in Alcohol Dependence | Phase 1/Phase 2 | Completed |
| NCT00483314 | 2007-11-01 | Homocystinuria: Treatment With N-Acetylcysteine | Phase 2 | Completed |
| NCT00575419 | 2007-11-01 | Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure | Phase 1 | Recruiting |
| NCT00552786 | 2007-11-01 | Antioxidation Medication for Noise-induced Hearing Loss | Phase 2 | Completed |
| NCT00506506 | 2007-10-01 | Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease | Phase 3 | Completed |
| NCT00532688 | 2007-09-01 | N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure | Phase 2/Phase 3 | Recruiting |
| NCT00539188 | 2007-09-01 | N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD | Phase 2 | Terminated |
| NCT00525551 | 2007-09-01 | Efficacy of Acetylcysteine in Patients Undergoing Surgery for Otosclerosis | Phase 4 | Completed |
| NCT00497328 | 2007-08-01 | COmbined N-acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of contrasT | Phase 2/Phase 3 | Completed |
| NCT00655928 | 2007-08-01 | Modulation of Lung Injury Complicating Lung Resection | Phase 2 | Completed |
| NCT00568113 | 2007-07-01 | N-Acetyl Cysteine for Prevention of Preterm Birth | Phase 4 | Completed |
| NCT00476736 | 2007-05-01 | The Effect of N-Acetylcystein on Quality of Life and Air Trapping During Rest and After Exercise | Phase 4 | Recruiting |
| NCT00467831 | 2007-04-01 | Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome | Phase 1/Phase 2 | Terminated |
| NCT00440869 | 2007-03-01 | Effects of N-acetylcysteine on Muscle Fatigue in Hemodialysis | Phase 1 | Completed |
| NCT00453180 | 2007-03-01 | A Study of Oral N-Acetylcysteine in Children With Autism Spectrum Disorders | Phase 2 | Completed |
| NCT00556465 | 2007-01-01 | Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic Nephropathy | Phase 2/Phase 3 | Completed |
| NCT00428883 | 2007-01-01 | High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis | Phase 2/Phase 3 | Recruiting |
| NCT00463749 | 2006-12-01 | Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein | Phase 3 | Completed |
| NCT01394497 | 2006-12-01 | Use of N-Acetylcysteine During Liver Procurement | Phase 2 | Completed |
| NCT00751257 | 2006-12-01 | N-Acetylcysteine and Smoking Reduction | Phase 2 | Completed |
| NCT00391911 | 2006-11-01 | Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis | Phase 2 | Completed |
| NCT00397735 | 2006-10-01 | N-acetylcysteine in Intra-amniotic Infection/Inflammation | Phase 1/Phase 2 | Recruiting |
| NCT00614679 | 2006-10-01 | A Novel Catheter Lock Solution for Treatment of Tunneled Hemodialysis Catheter-Associated Bacteremia | Phase 1 | Recruiting |
| NCT00998972 | 2006-09-01 | N-acetyl-cysteine (NAC) and Kidney Graft Function | Phase 3 | Completed |
| NCT00539513 | 2006-06-01 | N-Acetylcysteine Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder | Phase 2 | Terminated |
| NCT00337038 | 2006-06-01 | Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients | Phase 0 | Completed |
| NCT00808795 | 2006-04-01 | Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease | Phase 3 | Completed |
| NCT00267384 | 2006-03-01 | N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity | Phase 2/Phase 3 | Completed |
| NCT00611897 | 2006-01-01 | N-acetylcysteine and NMDA Antagonist Interactions | Phase 1/Phase 2 | Completed |
| NCT00512265 | 2006-01-01 | Influence of N-Acetylcysteine on Morbidity, Oxygenation and Cytokine Levels in Partial or Total Esophagectomy for Cancer | Phase 4 | Completed |
| NCT00218491 | 2005-11-01 | Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1 | Phase 2 | Completed |
| NCT00247507 | 2005-09-01 | The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients | Phase 4 | Active, Not Recruiting |
| NCT00374088 | 2005-02-01 | N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study) | Phase 2 | Completed |
| NCT00356954 | 2005-02-01 | NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization | Phase 4 | Completed |
| NCT00569465 | 2005-01-01 | N-Acetylcysteine and Arginine Administration in Diabetic Patients | Phase 4 | Terminated |
| NCT00190034 | 2005-01-01 | Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass. | Phase 4 | Suspended |
| NCT00238173 | 2004-12-01 | Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors | Phase 1 | Suspended |
| NCT00203099 | 2004-12-01 | Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine | Phase 2 | Completed |
| NCT00332631 | 2004-08-01 | High-Dose N-Acetylcysteine in Cardiac Surgery | Phase 2 | Completed |
| NCT00187330 | 2004-03-01 | A Study of The Effectiveness of N-Acetylcysteine in Kidney Protection Following Cardiopulmonary Bypass | Phase 2 | Completed |
| NCT00188773 | 2004-01-01 | Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion | Phase 4 | Completed |
| NCT00196885 | 2003-12-01 | Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training | Phase 2 | Completed |
| NCT00188630 | 2003-07-01 | N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery | Phase 3 | Completed |
| NCT00211653 | 2003-04-01 | Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery | Phase 1/Phase 2 | Completed |
| NCT00136825 | 2003-03-01 | Effectiveness of N-Acetylcysteine in Treating Cocaine Dependent Individuals - 1 | Phase 1 | Completed |
| NCT00237614 | 2003-02-01 | Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction | Phase 2/Phase 3 | Completed |
| NCT01223326 | 2003-01-01 | N-acetylcysteine to Reduce Ischemia/Reperfusion Injury in Liver Resection | Phase 4 | Completed |
| NCT00830193 | 2002-08-01 | N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography | Phase 2/Phase 3 | Completed |
| NCT01771978 | 2002-06-01 | Ischaemia-réperfusion During the Coronary Surgery With Beating Heart | Phase 3 | Active, Not Recruiting |
| NCT00122018 | 2002-05-01 | An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery | Phase 2 | Completed |
| NCT00492518 | 2002-02-01 | Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy | Phase 4 | Completed |
| NCT00962442 | 2000-09-01 | N-Acetylcysteine in Severe Acute Alcoholic Hepatitis | Phase 3 | Completed |
| NCT00639496 | 2000-03-01 | Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) | Phase 3 | Completed |
| NCT00248625 | 2000-01-01 | A Multi-center Study of the Safety and Efficacy of N-acetylcysteine in the Treatment of Acute Liver Failure in Pediatric Patients Not Caused by Acetaminophen. | Phase 3 | Completed |
| NCT00184977 | 1998-12-01 | COPD on Primary Care Treatment (COOPT) | Phase 4 | Completed |
| NCT00004467 | 1998-06-01 | Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen | Phase 3 | Completed |
| NCT00003346 | 1997-11-01 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma | Phase 2 | Completed |